Closing Figures: Precigen Inc (PGEN)’s Negative Finish at 1.57, Down -1.87

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

After finishing at $1.6 in the prior trading day, Precigen Inc (NASDAQ: PGEN) closed at $1.57, down -1.87%. In other words, the price has decreased by -$1.87 from its previous closing price. On the day, 2.83 million shares were traded. PGEN stock price reached its highest trading level at $1.6364 during the session, while it also had its lowest trading level at $1.545.

Ratios:

Our goal is to gain a better understanding of PGEN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.53 and its Current Ratio is at 3.53. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.29.

On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.

KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 463432608 and an Enterprise Value of 418125696. For the stock, the TTM Price-to-Sale (P/S) ratio is 110.34. Its current Enterprise Value per Revenue stands at 99.53 whereas that against EBITDA is -4.681.

Stock Price History:

The Beta on a monthly basis for PGEN is 1.87, which has changed by -0.03086418 over the last 52 weeks, in comparison to a change of 0.16932249 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 2.76%, while the 200-Day Moving Average is calculated to be 18.76%.

Shares Statistics:

The stock has traded on average 2.08M shares per day over the past 3-months and 3258010 shares per day over the last 10 days, according to various share statistics. A total of 295.14M shares are outstanding, with a floating share count of 146.25M. Insiders hold about 50.45% of the company’s shares, while institutions hold 27.37% stake in the company. Shares short for PGEN as of 1752537600 were 28429094 with a Short Ratio of 13.64, compared to 1749772800 on 27281305. Therefore, it implies a Short% of Shares Outstanding of 28429094 and a Short% of Float of 16.71.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.